Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SunWay Biotech CoROCO:1271 -4.39%90 Operating Margin % is 8.62% as of Dec. 2025, which is 41% below its 10-year median of 14.53. GuruFocus rates ROCO:1271 with a GF Score™ of 90/100 and a GF Value™ of NT$71.11 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, SunWay Biotech Co ranks better than 73.53% on this metric.
SunWay Biotech Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -24.9%.
The historical rank and industry rank for SunWay Biotech Co's Operating Margin % or its related term are showing as below:
ROCO:1271'
s Operating Margin % Range Over the Past 10 Years
Min: 9.14 Med: 14.53 Max: 44.09
Current: 10.48
ROCO:1271's Operating Margin % is ranked better than 73.53% of 1953
companies
in the Consumer Packaged Goods industry
Industry Median: 5.3
vs ROCO:1271: 10.48
SunWay Biotech Co's 5-Year Average Operating Margin % Growth Rate was -24.90% per year.
SunWay Biotech Co (ROCO:1271) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
SunWay Biotech Co Operating Margin % Related Terms
SunWay Biotech Co Operating Margin % Historical Data
* Premium members only.
The historical data trend for SunWay Biotech Co's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1271 vs KHC, GIS: Operating Margin % Comparison
For the Packaged Foods subindustry, SunWay Biotech Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SunWay Biotech Co Operating Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, SunWay Biotech Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where SunWay Biotech Co's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
SunWay Biotech Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SunWay Biotech Co (ROCO:1271) has a Operating Margin % of 8.62% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on SunWay Biotech Co and its competitors. This is 41% below median its historical median of 14.53. Over the past decade, SunWay Biotech Co's Operating Margin % has ranged from 9.14 to 44.09. According to the industry distribution chart, SunWay Biotech Co ranks #517 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 26.5%.
Is SunWay Biotech Co's Operating Margin % too high?
SunWay Biotech Co's current Operating Margin % of 8.62% is 41% below median its 10-year median of 14.53. Over the past 10 years, this metric has ranged from a low of 9.14 to a high of 44.09. The Consumer Packaged Goods industry median Operating Margin % is 5.30. SunWay Biotech Co's value of 8.62% is 62.6% above this industry median. Based on the distribution chart, SunWay Biotech Co ranks #517 out of 1953 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, SunWay Biotech Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SunWay Biotech Co's Operating Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, SunWay Biotech Co ranks #517 out of 1953 companies for Operating Margin %. This puts SunWay Biotech Co in the upper half of its industry. The industry median Operating Margin % is 5.30. SunWay Biotech Co's value of 8.62% is 62.6% above this benchmark. Historically, SunWay Biotech Co's own Operating Margin % has ranged from 9.14 to 44.09 over the past decade. While the company's 10-year median is 14.53 vs. the industry median of 5.30, SunWay Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Consumer Packaged Goods company?
The median Operating Margin % among Consumer Packaged Goods companies is 5.30, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SunWay Biotech Co's current Operating Margin % of 8.62% is 62.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on SunWay Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Operating Margin % is 5.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SunWay Biotech Co's current Operating Margin % is 8.62%, which is 41% below median its own 10-year median of 14.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SunWay Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, SunWay Biotech Co (ROCO:1271) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$71.11, compared to a current price of NT$61.00 — trading 14.2% below its estimated fair value. The current Operating Margin % is 8.62%, which is 41% below median its 10-year median of 14.53 and 62.6% above the Consumer Packaged Goods industry median of 5.30. SunWay Biotech Co's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For SunWay Biotech Co (ROCO:1271), the current Operating Margin % is 8.62% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SunWay Biotech Co (ROCO:1271) Overvalued in 2026?
Based on GuruFocus' analysis, SunWay Biotech Co stock appears to be undervalued.
The current stock price of NT$61.00 is trading 14.2% below its estimated GF Value™ of NT$71.11.
GuruFocus considers SunWay Biotech Co to be Modestly Undervalued.
Key valuation signals for ROCO:1271:
Operating Margin %: 8.62% (41% below median its 10-year median of 14.53)
GF Value™: NT$71.11 vs. price of NT$61.00 (14.2% below fair value)
Industry Position: 62.6% above the Consumer Packaged Goods median (#517 of 1953)
No single metric tells the full story. See the ROCO:1271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
90GF Score
Get the complete analysis for ROCO:1271
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1271 has been successfully added to your 
